Inhibikase Therapeutics

/Inhibikase Therapeutics

We are a clinical stage pharmaceutical company developing therapeutics for Parkinson’s Disease, or PD, and related disorders that arise inside and outside of the brain.

Symbol

Price Range
$10.00 - $12.00

Final Shares
1,363,000

Anticipated Date
December 23, 2020

Underwriters

This offering is no longer available

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange